Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Angiogenix Raises $12M In Series C For Acclaim Product

Dec. 19, 2002

By Aaron Lorenzo

Targeted Genetics Continues Cutbacks To Conserve Cash

Dec. 18, 2002

By Aaron Lorenzo

Versicor Starts Phase III Trials Of Dalbavancin For Infections

Dec. 18, 2002

By Aaron Lorenzo

Targeted Genetics Continues Cutbacks To Conserve Cash

Dec. 18, 2002

By Aaron Lorenzo

Versicor Starts Phase III Trials Of Dalbavancin For Infections

Dec. 18, 2002

By Aaron Lorenzo

AdipoGenix Lands Deal With J&J For Program In Obesity

Dec. 17, 2002

By Aaron Lorenzo

AdipoGenix Lands Deal With J&J For Program In Obesity

Dec. 17, 2002

By Aaron Lorenzo

Neurochem Raises C$8M, Could Realize More With Warrants Sale

Dec. 13, 2002

By Aaron Lorenzo

Neurochem Raises C$8M, Could Realize More With Warrants Sale

Dec. 13, 2002

By Aaron Lorenzo

Northwest, Medarex, Millennium Dealing Cancer Products, IP

Dec. 12, 2002

By Aaron Lorenzo